Why the study?
Cardiovascular disease represents the most frequent cause of morbidity and mortality in T1DM, prompting a review and meta-analysis of arterial stiffness measures in young patients.
Do children and adolescents with type 1 diabetes mellitus have increased arterial stiffness compared to healthy controls?
Do children and adolescents with type 1 diabetes mellitus have increased arterial stiffness compared to healthy controls?
Children and adolescents with type 1 diabetes mellitus exhibit early signs of increased arterial stiffness compared to healthy controls, highlighting early cardiovascular risk.
Children with T1DM show increased arterial stiffness; supports early vascular monitoring and extends observational evidence for preventive research.
AIMS: Cardiovascular disease (CVD) represents the most frequent cause of morbidity and mortality among patients with type 1 diabetes mellitus (T1DM). Our aim was to review the evidence and conduct a meta-analysis assessing measures of arterial stiffness by pulse wave velocity (PWV) and augmentation index (AIx) in children and adolescents with T1DM compared to healthy controls. METHODS: PubMed and the Cochrane Library were searched for relevant studies published up to 10 May 2021. RESULTS: Twenty-one studies were finally included in the meta-analysis. The T1DM group had significantly higher carotid to femoral PWV levels than that of the control group (mean difference [d]: 0.53 CI: 0.35-0.71, P < 0.00001) but with a fair heterogeneity (I 2:73%). By omitting one study with marked heterogeneity, mean difference in cfPWV remained significantly increased in the T1DM group compared to the control group (mean difference [d]: 0.37 CI: 0.27-0.48, P < 0.00001) but with improved heterogeneity (I2 = 26%). Regarding Aix, the T1DM group had a significantly higher AI@75 index than that of the control group (mean difference [d]: 0.28 CI: 0.17-0.39, P < 0.00001) and with no heterogeneity (I 2 = 8%). CONCLUSIONS: Youths with T1DM show increased arterial stiffness, either as increased carotid-femoral pulse wave velocity or increased augmentation index, early in their course of life compared to healthy controls. PROSPERO REGISTRATION NUMBER: CRD42021253236.
No takes yet. Share an insight, caveat, or question.
Christoforidis et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: